Kaplan‐Meier analysis revealed that only DLX5 expression was positively correlated with OS and LFS in both whole‐cohort AML (P = .012 and .010; Figure 1) and cytogenetically normal AML (CN‐AML) patients (P = .027 and .050; Figure 1), suggesting the negatively prognostic value of DLX5 expression in AML. The gene discussed is DLX5; the disease is acute myeloid leukemia.